Impact of immunosuppression and acute rejection on recurrence of hepatitis C: results of the National Institute of Diabetes and Digestive and Kidney Diseases Liver Transplantation Database.

Major challenges limiting liver transplantation in the United States. Am J Transplant (2011) 1.50

NIDDK data repository: a central collection of clinical trial data. BMC Med Inform Decis Mak (2006) 1.04

Living-donor liver transplantation and hepatitis C. HPB Surg (2013) 0.90

Posttransplant hyperglycemia is associated with increased risk of liver allograft rejection. Transplantation (2010) 0.88

Donor graft steatosis influences immunity to hepatitis C virus and allograft outcome after liver transplantation. Transplantation (2011) 0.84

Racial differences in fibrosis progression after HCV-related liver transplantation. Transplantation (2012) 0.82

A prospective, randomized trial of complete avoidance of steroids in liver transplantation with follow-up of over 7 years. HPB (Oxford) (2012) 0.81

Liver transplantation and hepatitis C. Int J Hepatol (2012) 0.79

Management of immunosuppressant agents following liver transplantation: Less is more. World J Hepatol (2016) 0.78

Acute Rejection Increases Risk of Graft Failure and Death in Recent Liver Transplant Recipients. Clin Gastroenterol Hepatol (2016) 0.77

Management of HCV infection and liver transplantation. Int J Med Sci (2006) 0.77

Role of living donor liver transplantation in the treatment of hepatitis C virus infection. Hepat Mon (2011) 0.77

Contradictory immune response in post liver transplantation hepatitis B and C. Int J Inflam (2014) 0.76

IL-2 Receptor Antagonist (Basiliximab) Is Associated with Rapid Fibrosis Progression in Patients with Recurrent Hepatitis C after Liver Transplantation Using Serial Biopsy Specimens. Int J Organ Transplant Med (2010) 0.76

Hepatitis C: New challenges in liver transplantation. World J Gastroenterol (2015) 0.76

Two-Year Follow-Up Analysis of Telaprevir-Based Antiviral Triple Therapy for HCV Recurrence in Genotype 1 Infected Liver Graft Recipients as a First Step towards Modern HCV Therapy. Hepat Res Treat (2016) 0.75

Pathological Roles of Interleukin-22 in the Development of Recurrent Hepatitis C after Liver Transplantation. PLoS One (2016) 0.75

Prevention of hepatitis C recurrence after liver transplantation: An update. World J Gastrointest Pharmacol Ther (2012) 0.75

Proteoforms in Peripheral Blood Mononuclear Cells as Novel Rejection Biomarkers in Liver Transplant Recipients. Am J Transplant (2017) 0.75

Intravenous interferon administered during liver transplantation is not effective in preventing hepatitis C reinfection. Dig Dis Sci (2013) 0.75

Differences in Phenotypes and Liver Transplantation Outcomes by Age Group in Patients with Primary Sclerosing Cholangitis. Dig Dis Sci (2017) 0.75

Predictors of patient and graft survival following liver transplantation for hepatitis C. Hepatology (1998) 1.95

Sensitivity and specificity for dementia of population-based criteria for cognitive impairment: the MoVIES project. J Gerontol (1993) 1.47

Predicting clinical and economic outcomes after liver transplantation using the Mayo primary sclerosing cholangitis model and Child-Pugh score. National Institutes of Diabetes and Digestive and Kidney Diseases Liver Transplantation Database Group. Liver Transpl (2000) 1.39

Effects of literacy and education on measures of word fluency. Brain Lang (1998) 0.95

Cognitive impairment and the use of health services in an elderly rural population: the MoVIES project. Monongahela Valley Independent Elders Survey. J Am Geriatr Soc (1993) 0.85

Studies of the epidemiology of dementia: comparisons between developed and developing countries. Aging (Milano) (1994) 0.84